Reply - 04/05/23
Doi : 10.1016/j.jaci.2023.01.025
Vamsi P. Guntur, MD, MSc a, b, ⁎ 
, Camille M. Moore, PhD c, Laurie A. Manka, MD a, b
, Camille M. Moore, PhD c, Laurie A. Manka, MD a, b a Division of Pulmonary, Critical Care, and Sleep Medicine, Denver, Colo
b NJH Cohen Family Asthma Institute, Denver, Colo
c Center for Genes, Environment and Health, National Jewish Health, Denver, Colo
∗Corresponding author: Vamsi P. Guntur, MD, MSc, Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, 1400 Jackson St, Denver, CO 80206.Division of PulmonaryCritical Care, and Sleep MedicineNational Jewish Health1400 Jackson StDenverCO80206
Le texte complet de cet article est disponible en PDF.
| This study was supported by Cohen Family Asthma Institute and AstraZeneca MedImmune, Gaithersburg, Md. |
|
| Disclosure of potential conflict of interest: V. P. Guntur has participated in Advisory Board for AstraZeneca and Speaker Bureau for Regeneron. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2023
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 151 - N° 5
P. 1411 - mai 2023 Retour au numéro
Article précédent
- Importance of mucus burden and mucociliary impairment in asthma
- Natsuko Nomura, Hisako Matsumoto, Hironobu Sunadome, Tsuyoshi Oguma, Toyohiro Hirai
- Plasma proteins defending infected, intact nasal mucosa
- Carl Persson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?